Skip to main content
OpenTrials

Clinical trial condition

Parkinson Disease 4, Autosomal Dominant Lewy Body

Explore clinical trials studying Parkinson Disease 4, Autosomal Dominant Lewy Body. Study availability and eligibility vary by location and protocol.

229 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body trial results

Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

NCT06961006

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations
  • Highlands Oncology Group ( Site 4042) Springdale, Arkansas, United States
  • UCSF Medical Center at Mission Bay ( Site 4044) San Francisco, California, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 4047) Hackensack, New Jersey, United States
  • Inova Schar Cancer Institute ( Site 4046) Fairfax, Virginia, United States
View all 38 locations
View Trial Details
Recruiting

A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors

NCT07147348

Conditions
Advanced Solid Tumor, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • Cancer Research SA Adelaide, Australia
  • Monash Medical Centre Clayton, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • The Alfred Hospital Melbourne, Australia
View all 17 locations
View Trial Details

Related conditions